Search
SOLACI Congress
N1 Revista de Cardiología Invasiva - Selección Marzo 2015

Procedimientos percutáneos combinados en defectos estructurales y congénitos

solaci
solaci
119
0
6_francisco_chamie_articulo

Francisco Chamié, Daniel Chamié, Luiz Carlos do Nascimento Simões, Renata Mat

Previous article
OPTIDUAL: Dual Antiaggregation Not Beneficial after 12 Months.
Next article
Polymer Free Drug Coated Stent in High Bleeding Risk Patients with Only One Month DAPT
solaci
solaci

More articles by this author

Tratamiento percutáneo de pseudoaneurismas del ventrículo izquierdo y de la aorta: serie de tres casos

solaci - 0
João Luiz Langer Manica, Luciano Pereira Bender, Mônica Scott Borges, Paulo Roberto Lunardi Prates, Raul Ivo Rossi-Filho

Seguridad y predictores de éxito del alta hospitalaria en el mismo día luego de intervención coronaria percutánea electiva

solaci - 0
Fabio Conejo, Henrique Barbosa Ribeiro, André Gasparini Spadaro, Roger Renault Godinho,  Sandro M. Faig, Camila Gabrilaitis, Mariana Y. Okada, Alexandre Spósito, Carlos Vinícius Espirito-Santo,...

Respuesta vascular tras implante de stents eluidores de biolimus A9 con polímero bioabsorbible y stents liberadores de everolimus con polímero durable. Resultados del análisis...

solaci - 0
Daniel Chamié, Breno O. Almeida, Fábio Grandic, Evandro M. Filho, J. Ribamar Costa Jr., Ricardo Costa, Rodolfo Staicoa, Dimytri Siqueira, Fausto Feres, Luiz Fernando...

Seguimiento de 12 meses de pacientes complejos tratados con stents farmacológicos liberadores de everolimus XIENCE V® en la práctica diaria – resultados del registro...

solaci - 0
Investigadores del Estudio BRAVO

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

N1 Revista de Cardiología Invasiva - Selección Marzo 2015

Tratamiento percutáneo de pseudoaneurismas del ventrículo izquierdo y de la aorta: serie de tres casos

João Luiz Langer Manica, Luciano Pereira Bender, Mônica Scott Borges, Paulo Roberto Lunardi Prates, Raul Ivo Rossi-Filho
solaci -
SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

Dr. Carlos Fava - 0
One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Dr. Andrés Rodríguez - 0
Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Dr. Omar Tupayachi - 0
Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

TAVR in Small Annuli: What Valve Should We Use?

Dr. Carlos Fava - 0
One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Dr. Andrés Rodríguez - 0
Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Dr. Omar Tupayachi - 0
Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

Institutional News

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

solaci - 0
The Latin American Society of Interventional Cardiology invites you to a new virtual event hosted by the SOLACI Research Department, aimed at clarifying doubts,...

Watch our event on Evidence and Controversies of Renal Denervation in 2025

solaci - 0
You can now watch our event, held in collaboration with Medtronic, titled "Evidence and Controversies of Renal Denervation in 2025." The event featured international experts...

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

solaci - 0
The Latin American Society of Interventional Cardiology invites you to a new virtual event supported by Medtronic. On this occasion, we will hold a 60-minute...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy